Cargando…

Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial

BACKGROUND: Treatment of dysplastic Barrett's oesophagus prevents progression to adenocarcinoma; however, the optimal diagnostic strategy for Barrett's oesophagus is unclear. The Cytosponge-trefoil factor 3 (TFF3) is a non-endoscopic test for Barrett's oesophagus. The aim of this stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fitzgerald, Rebecca C, di Pietro, Massimiliano, O'Donovan, Maria, Maroni, Roberta, Muldrew, Beth, Debiram-Beecham, Irene, Gehrung, Marcel, Offman, Judith, Tripathi, Monika, Smith, Samuel G, Aigret, Benoit, Walter, Fiona M, Rubin, Greg, Sasieni, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408501/ https://www.ncbi.nlm.nih.gov/pubmed/32738955 http://dx.doi.org/10.1016/S0140-6736(20)31099-0

Ejemplares similares

Barrett’s oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux
por: Offman, Judith, et al.
Publicado: (2018)

Acceptability of the Cytosponge procedure for detecting Barrett's oesophagus: a qualitative study
por: Freeman, Madeleine, et al.
Publicado: (2017)

Economic evaluation of Cytosponge®-trefoil factor 3 for Barrett esophagus: A cost-utility analysis of randomised controlled trial data
por: Swart, Nicholas, et al.
Publicado: (2021)

Detecting Barrett oesophagus using Cytosponge
por: Hindson, Jordan
Publicado: (2020)

Predictors of the experience of a Cytosponge test: analysis of patient survey data from the BEST3 trial
por: Ghimire, Bhagabati, et al.
Publicado: (2023)

Patient-reported experiences and views on the Cytosponge test: a mixed-methods analysis from the BEST3 trial
por: Maroni, Roberta, et al.
Publicado: (2022)

Use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance: a cross-sectional study followed by a real-world prospective pilot
por: Pilonis, Nastazja Dagny, et al.
Publicado: (2022)

Use of Cytosponge as a triaging tool to upper gastrointestinal endoscopy during the COVID-19 pandemic
por: di Pietro, Massimiliano, et al.
Publicado: (2020)

Methylation panel is a diagnostic biomarker for Barrett’s oesophagus in endoscopic biopsies and non-endoscopic cytology specimens
por: Chettouh, Hamza, et al.
Publicado: (2018)

Real-world implementation of non-endoscopic triage testing for Barrett’s oesophagus during COVID-19
por: Landy, R, et al.
Publicado: (2023)

Cytosponge-TFF3 Testing can Detect Precancerous Mucosal Changes of the Stomach
por: Hadjinicolaou, ANDREAS V., et al.
Publicado: (2022)

Impact of Barrett oesophagus diagnoses and endoscopies on oesophageal cancer survival in the UK: A cohort study
por: Offman, Judith, et al.
Publicado: (2021)

Evaluation of a Minimally Invasive Cell Sampling Device Coupled with Assessment of Trefoil Factor 3 Expression for Diagnosing Barrett's Esophagus: A Multi-Center Case–Control Study
por: Ross-Innes, Caryn S., et al.
Publicado: (2015)

Acceptability and accuracy of a non-endoscopic screening test for Barrett’s oesophagus in primary care: cohort study
por: Kadri, Sudarshan R, et al.
Publicado: (2010)

Update on endoscopic treatment of Barrett’s oesophagus and Barrett’s oesophagus–related neoplasia
por: Pech, Oliver, et al.
Publicado: (2020)

Barrett's oesophagus and adenocarcinoma
por: Caygill, Christine PJ, et al.
Publicado: (2004)

Management of Barrett's oesophagus
por: Mannath, Jayan, et al.
Publicado: (2009)

Trends and projections in adenocarcinoma and squamous cell carcinoma of the oesophagus in England from 1971 to 2037
por: Offman, Judith, et al.
Publicado: (2018)

The utility of P53 immunohistochemistry in the diagnosis of Barrett's oesophagus with indefinite for dysplasia
por: Januszewicz, Wladyslaw, et al.
Publicado: (2022)

Diagnosis and management of Barrett’s oesophagus
por: Jankowski, Janusz, et al.
Publicado: (2010)

The metaplastic mosaic of Barrett’s oesophagus
por: Biswas, Sujata, et al.
Publicado: (2018)

Barrett’s oesophagus: Current controversies
por: Amadi, Chidi, et al.
Publicado: (2017)

Computational pathology aids derivation of microRNA biomarker signals from Cytosponge samples
por: Masqué-Soler, Neus, et al.
Publicado: (2022)

Monitoring the premalignant potential of Barrett's oesophagus'
por: Graham, David, et al.
Publicado: (2016)

Screening for Barrett's oesophagus: is now the time?
por: Hanada, Yuri, et al.
Publicado: (2020)

Screening for Barrett’s Oesophagus: Are We Ready for it?
por: Yusuf, Aisha, et al.
Publicado: (2021)

Use of a non-endoscopic immunocytological device (Cytosponge™) for post chemoradiotherapy surveillance in patients with oesophageal cancer in the UK (CYTOFLOC): A multicentre feasibility study
por: Jones, Christopher M., et al.
Publicado: (2022)

A88 EVALUATING THE ACCEPTABILITY AND EFFICACY OF CYTOSPONGE FOR BARRETT'S ESOPHAGUS: A SINGLE CENTRE CROSS-SECTIONAL STUDY
por: Alqattan, A E, et al.
Publicado: (2023)

Quantification of TFF3 expression from a non-endoscopic device predicts clinically relevant Barrett's oesophagus by machine learning
por: Berman, Adam G., et al.
Publicado: (2022)

Metallothionein in human oesophagus, Barrett's epithelium and adenocarcinoma
por: Coyle, P, et al.
Publicado: (2002)

Influence of Life Style Factors on Barrett's Oesophagus
por: Horna Strand, A., et al.
Publicado: (2014)

Oesophageal xanthalasma with Barrett’s Oesophagus and Menetrier’s Disease
por: Mason, A, et al.
Publicado: (2011)

Genetic progression of Barrett's oesophagus to oesophageal adenocarcinoma
por: Gregson, Eleanor M, et al.
Publicado: (2016)

Extrachromosomal DNA in the cancerous transformation of Barrett’s oesophagus
por: Luebeck, Jens, et al.
Publicado: (2023)

Quality of life measures in dysplastic Barrett’s oesophagus are comparable to patients with non-dysplastic Barrett’s oesophagus and do not improve after endoscopic therapy
por: Ratcliffe, Elizabeth, et al.
Publicado: (2023)

Differential SPARC mRNA expression in Barrett's oesophagus
por: Brabender, J, et al.
Publicado: (2003)

The combination of autofluorescence endoscopy and molecular biomarkers is a novel diagnostic tool for dysplasia in Barrett's oesophagus
por: di Pietro, Massimiliano, et al.
Publicado: (2015)

Does laparoscopic Nissen fundoplication prevent the progression of Barrett’s oesophagus? Is the length of Barrett’s a factor?
por: Bamehriz, Fahad, et al.
Publicado: (2005)

Barrett's oesophagus: A qualitative study of patient burden, care delivery experience and follow‐up needs
por: Britton, James, et al.
Publicado: (2018)

Barrett’s oesophagus: Is there a need for laparoscopic anti-reflux surgery?
por: Sarela, Abeezar I.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_fkm57pks15rfdg1lros6rhugmq